Expanding Therapeutic Reach Antibody-Conjugated Lipid Nanoparticles to Enhance Extrahepatic Nucleic Acid Delivery

2:30 pm - Tuesday 21st July 2026

  • Showcasing targeted LNP for enhanced bone marrow delivery: Multi-level biodistribution analysis
  • Highlighting key formulation and ligand design principles that enable effective extrahepatic delivery beyond the liver

Speakers:

Associate Principal Scientist
AstraZeneca